openPR Logo
Press release

Growth Predictions on Global Hyperemesis Gravidarum Treatment Market Through 2028 Presented in New Forecast Research With Competition Tracking- Duchesnay, Ipca Laboratories Ltd., Medichem S.A., Novartis, Midatech Pharma US, and Genentech

11-26-2018 09:22 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and anti-hitamines medications. Sometimes, in case of hospitalization intravenous fluid is given to the mother to restore the electrolyte balance, nutrients, and vitamins. Hyperemesis gravidarum treatment depends on the severity of symptoms in patients. Hyperemesis gravidarum needs to be diagnosed as early as possible to reduce the risk of morbidity of both mother and foetus.

Get Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2183

As per a recent literature survey conducted by the State University of New York (SUNY) reveals that approximately 0.3 to 3% of pregnancy cases need hyperemesis gravidarum treatment.

Hyperemesis Gravidarum Treatment Market: Drivers and Restraints

The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the hyperemesis gravidarum treatment market. However, the high price of drugs may hinder the growth of the hyperemesis gravidarum treatment market.

Hyperemesis Gravidarum Treatment Market: Segmentation

Tentatively, the global hyperemesis gravidarum treatment market can be segmented on the basis of type of treatment, route of administration and distribution channel.

Based on Type of Treatment, the global hyperemesis gravidarum treatment market is segmented into:

Anti-histamine (Diclectin)
Prokinetic agent (Metoclopramide, Cisapride)
Vitamin-Mineral Supplement Tablets/ Dietary supplements (Pregvit)
Anti-reflux medications (Ranitidine, Lansoprazole)
Anti-emetic (Ondensetron)
Antacid

Other measures of treatment (Intravenous Fluid)

To Get Complete Report with Table of Content, Visit @ https://www.factmr.com/report/2183/hyperemesis-gravidarum-treatment-market

Based on Route of Administration (RoA), the global hyperemesis gravidarum treatment market is segmented into:

Peroral
Intravenous
Based on Distribution Channel, the global hyperemesis gravidarum treatment market is segmented into:

Pharmacy
Retailers
Wholesaler

Hyperemesis Gravidarum Treatment Market: Overview

The dietary supplements and anti-emetic medications are expected to generate significant revenue over the forecast in the global hyperemesis gravidarum treatment market, followed by prokinetic agents. People prefer OTC products rather than prescription drugs for hyperemesis gravidarum treatment, which is expected to drive the growth of the retail segment over the forecast period. Based on RoA, intravenous treatment is gaining popularity for hyperemesis gravidarum treatment because in this way the drugs directly get absorbed into the blood-stream, leaving no option to irritate the gastric mucosa. Some of the popular brands of hyperemesis gravidarum treatment include Diclectin (Duchesnay Inc.), Pregvit (Duchesnay Inc.), Zofran (Novartis AG), Zuplenz (Midatech Pharma US Inc.), Kytril (Genentech, Inc.), etc. 

Hyperemesis Gravidarum Treatment Market: Regional Outlook

Geographically, the global hyperemesis gravidarum treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa. North America is expected to be the dominant regional market for hyperemesis gravidarum treatment due to the growing awareness regarding use of prescription drugs. Europe is expected to contribute second large revenue share in the global hyperemesis gravidarum treatment market throughout the forecast period due increasing number of patients with need of hyperemesis gravidarum treatment. With increase in the expenditure for healthcare sector and growing awareness regarding hyperemesis gravidarum treatment among general population, the hyperemesis gravidarum treatment market is expected to grow at a significant CAGR in Asia Pacific. 

Hyperemesis Gravidarum Treatment: Key Players

The global Hyperemesis Gravidarum Treatment is highly fragmented with a large number of global players operating. Examples of some of the key players identified in the global hyperemesis gravidarum treatment market are Duchesnay Inc., Ipca Laboratories Ltd., Medichem S.A., Novartis AG, Midatech Pharma US Inc., and Genentech, Inc., among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. 

Report Highlights: 

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Grow Your Business From Expert Advice @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=2183

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market Insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth Predictions on Global Hyperemesis Gravidarum Treatment Market Through 2028 Presented in New Forecast Research With Competition Tracking- Duchesnay, Ipca Laboratories Ltd., Medichem S.A., Novartis, Midatech Pharma US, and Genentech here

News-ID: 1397756 • Views: 431

More Releases from Fact.MR

Auto Infotainment Market Growth Analyzed to 2026 | Continental AG, HARMAN Inter …
Fact.MR is a leading market research entity that, with its primary and secondary research mechanisms can bring a tectonic shift in the growth rate of the Auto Infotainment market. Fact.MR leads the way of your business toward success through the help of exceptional market leaders and experts having diverse experience in the Auto Infotainment market. Fact.MR analysis on auto infotainment market covers value projections of the market. According to the
Fact.MR Report: What are the Key Growth Drivers of Insulation Blow-in Machine M …
The presence of a seamless industrial manufacturing sector has created new avenues for growth within the global Insulation Blow-in Machine market. The coherence of sales within this market is a function of the efforts made by leading stakeholders and vendors in promoting the products. The absence of a viable alternative has also brought the Insulation Blow-in Machine market under the spotlight of focus. The favorability of government regulations for the
Lightweight Materials Account for More Than 1/3rd Share in the Global Suspended …
Suspended Scaffolding Market: Introduction Suspended scaffolding are raised aerial platforms suspended by ropes fixed atop the highest point of any structure i.e.; buildings, towers among others. These platforms move about the outer façade of a building and can be raised or lowered via the ropes connected to a motor. Suspended scaffoldings are utilized whenever maintenance and cleaning work has to be carried out on the facade of any tall structure. These
Key Factors Shaping the Dryer Vents Market | Defleco ,LLC, Dundas Jafine Inc., …
Fact.MR has recently announced the addition of a new study on the global Dryer Vents market to its document repository. This report is intended to provide a detailed analysis of all vital factors impacting negatively or positively on the development of the Dryer Vents market during the assessment period of 2019 2029. Apart from this, the latest study highlights historical and current trends together with forecast on future trends shaping

All 5 Releases


More Releases for Hyperemesis

04-19-2019 | Health & Medicine
Fact.MR
Global Hyperemesis Gravidarum Market Projections Analyzed To Inspect Growth Tren …
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price
Global Hyperemesis Gravidarum Treatment Market Projected to Augment at a Notable …
This research assessment managed by FactMR works to highlight the expected transformations that will occur in the “Hyperemesis Gravidarum Treatment Market” market in the coming years. FactMR has worked diligently to compile primary market facets through this report titled “Global Hyperemesis Gravidarum Treatment Market Scenario Highlighting Major Drivers & Trends, 2018-2028” which will soon be published for benefitting the readers. The availability of crucial statistics such as market revenue, market
Global Hyperemesis Gravidarum Treatment Market Scenario Highlighting Major Drive …
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price
Central Pontine Myelinolysis Market Treatment Methods Analysis 2019 with Key Pla …
The market drivers for Central Pontine Myelinolysis Market are increasing risk factors and cases of liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc. Global Central Pontine Myelinolysis Market - Key players Some of key players profiled in the report
Central Pontine Myelinolysis Market with Major Players Like Fujifilm Holdings Co …
Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms. These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures
10-30-2018 | Health & Medicine
Fact.MR
Hyperemesis Gravidarum Treatment Market Projected to Experience Major Revenue Bo …
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and